Michael P. Dube serves as Executive at Intellia Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael P. Dube has executed 2 insider transactions totaling $32.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 1, 2025 involved selling 1,871 shares valued at $32.5K.
Michael P. Dube currently holds 55,266 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael P. Dube has been a net seller of NTLA stock. They have purchased $0 and sold $32.5K worth of shares.
Michael P. Dube's most recent insider trade was on Oct 1, 2025, when they sold 1,871 shares at $17.38 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |